Synovate Healthcare launches Diabetes Therapy Monitor in China
Synovate Healthcare — the healthcare arm of global research agency, Synovate – has announced the launch of the Synovate Healthcare Diabetes Therapy Monitor in China. The new monitor is a syndicated study combining detailed patient medical records with doctor and patient perceptions, providing comprehensive data on the diabetes market.
Launched in April, the new monitor currently offers clients access to some 4000 patient records and 200 diabetes specialists in the country. It will be extended to other key Asian markets over the next year – a development that will enable Synovate Healthcare’s clients to compare and contrast the treatment of diabetes across Asia Pacific.
The diabetes monitor is the latest addition to Synovate Healthcare’s extensive therapy monitor portfolio, which covers oncology, antiviral and autoimmune diseases globally.
Commenting on the new monitor, Synovate Healthcare’s Sabina Heinz said, “This is an exciting development for Synovate Healthcare and for our clients. Now, clients can understand diabetes patient management and treatment in the region – not just based on doctors’ perceptions of what they do, but what they actually do”.
For more information on the Synovate Healthcare Diabetes Monitor, contact Sabina Heinz at email@example.com or on +65 6430 6884.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.